Skip to content

Summit Therapeutics SMMT Compensation and benefits

Compensation and benefits at other companies

Incyte logo
IncyteINCY
Roivant Sciences logo
Roivant SciencesROIV
Johnson & Johnson logo
Johnson & JohnsonJNJ
Eli Lilly logo
Eli LillyLLY
Moderna logo
ModernaMRNA

Other financials

Income statement

See full
Revenue-
Operating income-$65.6M-81.2%
Net income-$189.4M-201%
EPS (diluted)-$0.24-167%

Balance sheet

See full
Cash & equivalents$8.2M+7.2%
Total debt$20.0M+211%
Total equity$545.9M+58.5%
Total assets$647.9M+68.8%

Cash flow

See full
Operating cash flow-$122.3M-99.9%
CapEx$245.0K-41.9%
Free cash flow-$122.5M-99.0%

Valuation

See full
Market cap$10.67B+3.3%
Enterprise value$10.68B+3.4%

Profitability

See full
Operating margin-268,266.8%-272,316pp
Net margin-271,685%-275,966pp
FCF margin-5,931.6%+4,730pp

Returns & leverage

See full
Return on equity-271%-1,725pp
Debt / equity0.0×
Current ratio7.4×-3.2×

Where this comes from

Reported directly by Summit Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Summit Therapeutics's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Summit Therapeutics's compensation and benefits?
Summit Therapeutics (SMMT) reported compensation and benefits of $7.07M in Q1 2026.
How has Summit Therapeutics's compensation and benefits changed year-over-year?
Summit Therapeutics's compensation and benefits increased by 60.9% year-over-year, from $4.4M to $7.07M.
What is the long-term trend for Summit Therapeutics's compensation and benefits?
Over 5 years (2020 to 2025), Summit Therapeutics's compensation and benefits has grown at a 72.3% compound annual growth rate (CAGR), from $983K to $14.93M.